These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 314334)

  • 21. Identification of tumor-associated antigens on ultraviolet light-induced tumors using antitumor antibodies developed in ascites fluid.
    Fortner GW; Takemoto LJ; Shehi L; Hansen JS
    Cancer Res; 1982 Jun; 42(6):2371-4. PubMed ID: 7042083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotherapy of a carcinogen-induced murine sarcoma with soluble tumor-specific transplantation antigens.
    Kahan BD; Tanaka T; Pellis NR
    J Natl Cancer Inst; 1980 Nov; 65(5):1001-4. PubMed ID: 6159495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological intervention in neoplasia.
    Weiss DW
    Johns Hopkins Med J Suppl; 1974; 3():131-56. PubMed ID: 4371312
    [No Abstract]   [Full Text] [Related]  

  • 24. Establishment of a tumor-specific immunotherapy model utilizing TNP-reactive helper T cell activity and its application to the autochthonous tumor system.
    Fujiwara H; Aoki H; Yoshioka T; Tomita S; Ikegami R; Hamaoka T
    J Immunol; 1984 Jul; 133(1):509-14. PubMed ID: 6233375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonspecific Immunotherapy of Murine Solid Tumors With Corynebacterium granulosum.
    Milas L; Hunter B; Mason K; Grdina D; Withers H
    J Natl Cancer Inst; 1975 Apr; 54(4):895-902. PubMed ID: 1127718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies to rat sarcomata. II. A syngeneic IgG2b antibody with anti-tumour activity.
    North SM; Dean CJ
    Immunology; 1983 Aug; 49(4):667-71. PubMed ID: 6874004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Augmentation of specific anti-tumor immunity by immunization with xenogenized tumor cells and its application to the experimental cancer treatment (author's transl)].
    Okayasu T
    Hokkaido Igaku Zasshi; 1981 Nov; 56(6):615-22. PubMed ID: 7338338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L; Hunter N; Mason K; Withers HR
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract]   [Full Text] [Related]  

  • 29. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
    Gomi K; Morimoto M; Nomoto K
    Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects on tumor growth in vivo by manipulation of the tumor immune response.
    Sjögren HO
    Johns Hopkins Med J Suppl; 1974; 3():51-60. PubMed ID: 4370816
    [No Abstract]   [Full Text] [Related]  

  • 31. [Correlation between intracellular cyclic AMP level and cytotoxic sensitivity to anti-tumor-associated antigen antibody in rat fibrosarcoma cells].
    Saito T
    Hokkaido Igaku Zasshi; 1988 Nov; 63(6):882-8. PubMed ID: 2854817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regression of untreated tumor following immunotherapy of primary tumor in rats.
    Arai K; Wallace HW; Blakemore WS
    Surg Forum; 1973; 24():117-8. PubMed ID: 4805961
    [No Abstract]   [Full Text] [Related]  

  • 33. Specific tumor immunity induced with mitomycin C-treated syngeneic tumor cells (MCT). Effects of carrageenan and trypan blue on MCT-induced immunity in mice.
    Wu RL; Kearney R
    J Natl Cancer Inst; 1980 Jan; 64(1):81-7. PubMed ID: 6928050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
    Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective immunity to progressive tumors can be induced by antigen presented on regressor tumors.
    Flood PM; Schreiber H; Ron Y
    J Immunol; 1987 May; 138(10):3573-9. PubMed ID: 3571978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the effects of anti-Thy-1.2 monoclonal antibody and xenogeneic antithymocyte serum on the development of SaI tumor allograft in mice.
    Sobotková E; Sůla K; Nouza K
    Neoplasma; 1988; 35(4):361-7. PubMed ID: 3263580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure of Bacillus Calmette-Guérin (BCG) infection to suppress the growth of transplanted mouse and rat sarcomas.
    Símová J; Bubeník J
    Folia Biol (Praha); 1973; 19(4):296-300. PubMed ID: 4356560
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice.
    Rios A; Simmons RL
    Cancer Res; 1972 Jan; 32(1):16-21. PubMed ID: 4550256
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunotherapy of murine sarcomas with auto-anti-idiotypic monoclonal antibodies which bind to tumor-specific T cells.
    Nelson KA; George E; Swenson C; Forstrom JW; Hellström KE
    J Immunol; 1987 Sep; 139(6):2110-7. PubMed ID: 2957449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor activity of bacterial infection. I. Effect of Listeria monocytogenes on growth of a murine fibrosarcoma.
    Bast RC; Zbar B; Mackaness GB; Rapp HJ
    J Natl Cancer Inst; 1975 Mar; 54(3):749-56. PubMed ID: 804566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.